Pressure Bio, Digilab Join in Co-marketing, R&D Effort | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences and Digilab have struck an agreement to co-market and sell their product lines together worldwide and to pursue joint research and development projects, Digilab said today.

The companies plan to co-market their respective technologies through industry publications, at scientific meetings, through their websites, at trade shows, and through common collaborator studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.